| Year |
Citation |
Score |
| 2020 |
Pucciarelli D, Angus SP, Huang B, Zhang C, Nakaoka HJ, Krishnamurthi G, Bandyopadhyay S, Clapp DW, Shannon K, Johnson GL, Nakamura JL. Nf1 mutant tumors undergo transcriptome and kinome re-modeling after inhibition of either mTOR or MEK. Molecular Cancer Therapeutics. PMID 32847978 DOI: 10.1158/1535-7163.Mct-19-1017 |
0.317 |
|
| 2020 |
Maynard A, McCoach CE, Rotow JK, Harris L, Haderk F, Kerr DL, Yu EA, Schenk EL, Tan W, Zee A, Tan M, Gui P, Lea T, Wu W, Urisman A, ... ... Bandyopadhyay S, et al. Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing. Cell. PMID 32822576 DOI: 10.1016/J.Cell.2020.07.017 |
0.314 |
|
| 2020 |
Wu CH, Yang CY, Wang L, Gao HX, Rakhshandehroo T, Afghani S, Pincus L, Balassanian R, Rubenstein J, Gill R, Bandyopadhyay S, McCormick F, Moasser M, Ai WZ. Cutaneous T cell lymphoma PDX drug screening platform identifies cooperation between inhibitions of PI3Kα/δ and HDAC. The Journal of Investigative Dermatology. PMID 32603749 DOI: 10.1016/J.Jid.2020.05.110 |
0.321 |
|
| 2020 |
Ku AA, Hu HM, Zhao X, Shah KN, Kongara S, Wu D, McCormick F, Balmain A, Bandyopadhyay S. Integration of multiple biological contexts reveals principles of synthetic lethality that affect reproducibility. Nature Communications. 11: 2375. PMID 32398776 DOI: 10.1038/S41467-020-16078-Y |
0.441 |
|
| 2019 |
Shah KN, Bhatt R, Rotow J, Rohrberg J, Olivas V, Wang VE, Kuhn J, Dumont S, Mccormick F, Goga A, Blakely CM, Bivona TG, Bandyopadhyay S. Abstract 2902: Non-genetic TPX2/AURKA signaling facilitates tumor evolution in EGFR-TKI resistance in NSCLC Cancer Research. 79: 2902-2902. DOI: 10.1158/1538-7445.Am2019-2902 |
0.355 |
|
| 2018 |
Webber JT, Kaushik S, Bandyopadhyay S. Integration of Tumor Genomic Data with Cell Lines Using Multi-dimensional Network Modules Improves Cancer Pharmacogenomics. Cell Systems. PMID 30414925 DOI: 10.1016/J.Cels.2018.10.001 |
0.343 |
|
| 2018 |
Donnella HJ, Webber JT, Levin RS, Camarda R, Momcilovic O, Bayani N, Shah KN, Korkola JE, Shokat KM, Goga A, Gordan JD, Bandyopadhyay S. Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy in breast cancer. Nature Chemical Biology. PMID 29942081 DOI: 10.1038/S41589-018-0081-9 |
0.346 |
|
| 2018 |
Hu HM, Zhao X, Kaushik S, Robillard L, Barthelet A, Lin KK, Shah KN, Simmons AD, Raponi M, Harding TC, Bandyopadhyay S. A Quantitative Chemotherapy Genetic Interaction Map Reveals Factors Associated with PARP Inhibitor Resistance. Cell Reports. 23: 918-929. PMID 29669295 DOI: 10.1016/J.Celrep.2018.03.093 |
0.394 |
|
| 2018 |
Martinko AJ, Truillet C, Julien O, Diaz J, Horlbeck MA, Whiteley G, Blonder J, Weissman JS, Bandyopadhyay S, Evans M, Wells JA. Targeting RAS driven human cancer cells with antibodies to upregulated and essential cell-surface proteins. Elife. 7. PMID 29359686 DOI: 10.7554/Elife.31098 |
0.3 |
|
| 2018 |
Donnella H, Webber J, Shokat K, Goga A, Gordan J, Bandyopadhyay S. Abstract A45: Kinome rewiring reveals AURKA is a molecular barrier to the efficacy of PI3K/mTOR-pathway inhibitors in breast cancer Molecular Cancer Research. 16. DOI: 10.1158/1557-3125.Advbc17-A45 |
0.339 |
|
| 2018 |
Kaushik S, Jang G, Hu H, Shah K, Zhao X, Jascur J, Dollen JV, Verschueren E, Johnson J, Krogan N, Bandyopadhyay S. Abstract 3297: A tyrosine kinase interactome reveals network states that guide the use of targeted therapies in cancer Cancer Research. 78: 3297-3297. DOI: 10.1158/1538-7445.Am2018-3297 |
0.425 |
|
| 2018 |
Shah KN, Bhatt R, Rotow J, Rohrberg J, Olivas V, Hemmati GG, Krings G, Haringsma HJ, Simmons AD, Harding TC, Goga A, Blakely C, Bivona T, Bandyopadhyay S. Abstract 1957: Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer Cancer Research. 78: 1957-1957. DOI: 10.1158/1538-7445.Am2018-1957 |
0.327 |
|
| 2017 |
Hu H, Bandyopadhyay S. Abstract PR07: Identifying factors mediating response and resistance to chemotherapy through a chemical-genetic interaction map Molecular Cancer Research. 15. DOI: 10.1158/1557-3125.Dnarepair16-Pr07 |
0.401 |
|
| 2017 |
Bandyopadhyay S. Abstract IA20: Chemical-genetic interaction maps for precision therapies in breast and ovarian cancers Molecular Cancer Therapeutics. 16. DOI: 10.1158/1538-8514.Synthleth-Ia20 |
0.394 |
|
| 2017 |
Ku AA, Bandyopadhyay S. Abstract A16: Discovery and functional characterization of essential pathways in KRAS mutant cancers Molecular Cancer Therapeutics. 16. DOI: 10.1158/1538-8514.Synthleth-A16 |
0.443 |
|
| 2016 |
Hofree M, Carter H, Kreisberg JF, Bandyopadhyay S, Mischel PS, Friend S, Ideker T. Challenges in identifying cancer genes by analysis of exome sequencing data. Nature Communications. 7: 12096. PMID 27417679 DOI: 10.1038/Ncomms12096 |
0.527 |
|
| 2016 |
Gerhard DS, Clemons PA, Shamji AF, Hon C, Wagner BK, Schreiber SL, Krasnitz A, Sordella R, Sander C, Lowe SW, Powers S, Smith K, Aburi M, Iavarone A, Lasorella A, ... ... Bandyopadhyay S, et al. Transforming Big Data into cancer-relevant insight: An initial, multi-tier approach to assess reproducibility and relevance. Molecular Cancer Research : McR. PMID 27401613 DOI: 10.1158/1541-7786.Mcr-16-0090 |
0.325 |
|
| 2016 |
Kohnz RA, Roberts LS, DeTomaso D, Bideyan L, Yan P, Bandyopadhyay S, Goga A, Yosef N, Nomura DK. Protein Sialylation Regulates a Gene Expression Signature that Promotes Breast Cancer Cell Pathogenicity. Acs Chemical Biology. PMID 27380425 DOI: 10.1021/Acschembio.6B00433 |
0.324 |
|
| 2016 |
Miller RE, Brough R, Bajrami I, Williamson CT, McDade S, Campbell J, Kigozi A, Rafiq R, Pemberton H, Natrajan R, Joel J, Astley H, Mahoney C, Moore JD, Torrance C, ... Bandyopadhyay S, et al. Synthetic Lethal Targeting of ARID1A-Mutant Ovarian Clear Cell Tumors with Dasatinib. Molecular Cancer Therapeutics. 15: 1472-84. PMID 27364904 DOI: 10.1158/1535-7163.Mct-15-0554 |
0.354 |
|
| 2016 |
Yang C, Faraj R, Rakhshandaroo T, Afghani S, Pincus L, Bandyopadhyay S, McCormick F, Ai W. Abstract 388: Pathway-directed high throughput drug screen identifies PI3K inhibitors that synergistically potentiate anti-tumor activity of HDAC inhibitors in mycosis fungoides and Sézary syndrome Cancer Research. 76: 388-388. DOI: 10.1158/1538-7445.Am2016-388 |
0.339 |
|
| 2015 |
Kohnz RA, Mulvihill MM, Chang JW, Hsu KL, Sorrentino A, Cravatt BF, Bandyopadhyay S, Goga A, Nomura DK. Activity-Based Protein Profiling of Oncogene-Driven Changes in Metabolism Reveals Broad Dysregulation of PAFAH1B2 and 1B3 in Cancer. Acs Chemical Biology. 10: 1624-30. PMID 25945974 DOI: 10.1021/Acschembio.5B00053 |
0.321 |
|
| 2015 |
Martins MM, Zhou AY, Corella A, Horiuchi D, Yau C, Rakshandehroo T, Gordan JD, Levin RS, Johnson J, Jascur J, Shales M, Sorrentino A, Cheah J, Clemons PA, Shamji AF, ... Bandyopadhyay S, et al. Linking tumor mutations to drug responses via a quantitative chemical-genetic interaction map. Cancer Discovery. 5: 154-67. PMID 25501949 DOI: 10.1158/2159-8290.Cd-14-0552 |
0.413 |
|
| 2015 |
Ai W, Yang C, Faraj R, Rakhshandhroo T, Afghani S, Pincus L, Bandyopadhyay S, McCormick F. Pathway-Directed High Throughput Drug Screen Identifies PI3K Inhibitors That Synergistically Potentiate Anti-Tumor Activity of HDAC Inhibitors in Mycosis Fungoides and Sezary Syndrome Blood. 126: 2755-2755. DOI: 10.1182/Blood.V126.23.2755.2755 |
0.334 |
|
| 2015 |
Zhou AY, Martins MM, Corella A, Horiuchi D, Yau C, Rakshandehroo T, Gordan JD, Levin RS, Johnson J, Jascur J, Shales M, Sorrentino A, Cheah J, Clemons PA, Shamji A, ... ... Bandyopadhyay S, et al. Abstract B48: Identification of novel drug interactions with MYC via a quantitative chemical-genetic interaction map Molecular Cancer Research. 13. DOI: 10.1158/1557-3125.Myc15-B48 |
0.414 |
|
| 2015 |
Zhou AY, Martins MM, Corella A, Horiuchi D, Yau C, Rakshandehroo T, Gordan JD, Levin RS, Johnson J, Jascur J, Shales M, Sorrentino A, Cheah J, Clemons PA, Shamji A, ... ... Bandyopadhyay S, et al. Abstract B44: A systems approach combining genomics, advocacy, and emerging novel therapeutics to address triple-negative breast cancer (TNBC) outcomes disparities Cancer Epidemiology, Biomarkers & Prevention. 24. DOI: 10.1158/1538-7755.Disp14-B44 |
0.375 |
|
| 2015 |
Martins MM, Zhou AY, Corella A, Horiuchi D, Yau C, Rakshandehroo T, Gordan JD, Levin RS, Johnson J, Jascur J, Shales M, Sorrentino A, Cheah J, Clemons PA, Shamji A, ... ... Bandyopadhyay S, et al. Abstract PR15: Functional analysis of diverse oncogenic driver mutations using an isogenic cell line library identifies novel drug responses and alterations in metabolism Cancer Research. 75. DOI: 10.1158/1538-7445.Transcagen-Pr15 |
0.402 |
|
| 2015 |
Martins MM, Zhou AY, Corella A, Horiuchi D, Yau C, Rakshandehroo T, Gordan JD, Levin RS, Johnson J, Jascur J, Shales M, Sorrentino A, Cheah J, Clemons PA, Shamji A, ... ... Bandyopadhyay S, et al. Abstract PR07: Functional analysis of diverse oncogenic driver mutations using an isogenic cell line library identifies novel drug responses and alterations in metabolism Cancer Research. 75. DOI: 10.1158/1538-7445.Compsysbio-Pr07 |
0.402 |
|
| 2015 |
Sarosiek KA, Karst A, Winter P, Sorrentino A, Bandyopadhyay S, Goga A, Wood KC, Drapkin R, Letai A. Abstract 970: Broad therapy resistance is induced by suppression of apoptotic priming by lineage programs and oncogenic activation Cancer Research. 75: 970-970. DOI: 10.1158/1538-7445.Am2015-970 |
0.308 |
|
| 2014 |
Sos ML, Levin RS, Gordan JD, Oses-Prieto JA, Webber JT, Salt M, Hann B, Burlingame AL, McCormick F, Bandyopadhyay S, Shokat KM. Oncogene mimicry as a mechanism of primary resistance to BRAF inhibitors. Cell Reports. 8: 1037-48. PMID 25127139 DOI: 10.1016/J.Celrep.2014.07.010 |
0.327 |
|
| 2014 |
Benjamin DI, Louie SM, Mulvihill MM, Kohnz RA, Li DS, Chan LG, Sorrentino A, Bandyopadhyay S, Cozzo A, Ohiri A, Goga A, Ng SW, Nomura DK. Inositol phosphate recycling regulates glycolytic and lipid metabolism that drives cancer aggressiveness. Acs Chemical Biology. 9: 1340-50. PMID 24738946 DOI: 10.1021/Cb5001907 |
0.31 |
|
| 2014 |
Lin L, Asthana S, Chan E, Bandyopadhyay S, Martins MM, Olivas V, Yan JJ, Pham L, Wang MM, Bollag G, Solit DB, Collisson EA, Rudin CM, Taylor BS, Bivona TG. Mapping the molecular determinants of BRAF oncogene dependence in human lung cancer. Proceedings of the National Academy of Sciences of the United States of America. 111: E748-57. PMID 24550319 DOI: 10.1073/Pnas.1320956111 |
0.325 |
|
| 2014 |
Sos ML, Levin R, Gordan J, Oses-Prieto J, Webber J, Salt M, Hann B, Burlingame A, Mccormick F, Bandyopadhyay S, Shokat K. Abstract LB-216: Integrated analysis of differential pathway resiliency in response to MAPK inhibition in BRAF-mutant cancer Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-216 |
0.39 |
|
| 2014 |
Braunstein S, Mroue R, Huang B, Bandyopadhyay S, Nakamura J. Abstract 68: Tumor operational signaling pathways in an Nf1 mutant mouse model system Cancer Research. 74: 68-68. DOI: 10.1158/1538-7445.Am2014-68 |
0.307 |
|
| 2014 |
Sos M, Levin R, Gordan J, Oses-Prieto J, Webber J, Salt M, Hann B, Burlingame A, McCormick F, Bandyopadhyay S, Shokat K. 73 Differential pathway resiliency in response to MAPK inhibition in BRAF-mutant cancer European Journal of Cancer. 50: 28-29. DOI: 10.1016/S0959-8049(14)70199-6 |
0.31 |
|
| 2013 |
Bushman FD, Barton S, Bailey A, Greig C, Malani N, Bandyopadhyay S, Young J, Chanda S, Krogan N. Bringing it all together: big data and HIV research. Aids (London, England). 27: 835-8. PMID 23719353 DOI: 10.1097/Qad.0B013E32835Cb785 |
0.34 |
|
| 2013 |
Roguev A, Talbot D, Negri GL, Shales M, Cagney G, Bandyopadhyay S, Panning B, Krogan NJ. Quantitative genetic-interaction mapping in mammalian cells. Nature Methods. 10: 432-7. PMID 23407553 DOI: 10.1038/Nmeth.2398 |
0.396 |
|
| 2012 |
Martins M, Bandyopadhyay S. Abstract B10: Development of a high-throughput screen to identify oncogene-mediated dependencies in transformed cancer cells. Cancer Research. 72. DOI: 10.1158/1538-7445.Panca2012-B10 |
0.365 |
|
| 2010 |
Bandyopadhyay S, Mehta M, Kuo D, Sung MK, Chuang R, Jaehnig EJ, Bodenmiller B, Licon K, Copeland W, Shales M, Fiedler D, Dutkowski J, Guénolé A, van Attikum H, Shokat KM, et al. Rewiring of genetic networks in response to DNA damage. Science (New York, N.Y.). 330: 1385-9. PMID 21127252 DOI: 10.1126/Science.1195618 |
0.564 |
|
| 2010 |
Kuo D, Licon K, Bandyopadhyay S, Chuang R, Luo C, Catalana J, Ravasi T, Tan K, Ideker T. Coevolution within a transcriptional network by compensatory trans and cis mutations. Genome Research. 20: 1672-8. PMID 20978140 DOI: 10.1101/Gr.111765.110 |
0.594 |
|
| 2010 |
Bandyopadhyay S, Chiang CY, Srivastava J, Gersten M, White S, Bell R, Kurschner C, Martin C, Smoot M, Sahasrabudhe S, Barber DL, Chanda SK, Ideker T. A human MAP kinase interactome. Nature Methods. 7: 801-5. PMID 20936779 DOI: 10.1038/Nmeth.1506 |
0.581 |
|
| 2010 |
König R, Stertz S, Zhou Y, Inoue A, Hoffmann HH, Bhattacharyya S, Alamares JG, Tscherne DM, Ortigoza MB, Liang Y, Gao Q, Andrews SE, Bandyopadhyay S, De Jesus P, Tu BP, et al. Human host factors required for influenza virus replication. Nature. 463: 813-7. PMID 20027183 DOI: 10.1038/Nature08699 |
0.524 |
|
| 2009 |
Fossum E, Friedel CC, Rajagopala SV, Titz B, Baiker A, Schmidt T, Kraus T, Stellberger T, Rutenberg C, Suthram S, Bandyopadhyay S, Rose D, von Brunn A, Uhlmann M, Zeretzke C, et al. Evolutionarily conserved herpesviral protein interaction networks. Plos Pathogens. 5: e1000570. PMID 19730696 DOI: 10.1371/Journal.Ppat.1000570 |
0.722 |
|
| 2009 |
Bushman FD, Malani N, Fernandes J, D'Orso I, Cagney G, Diamond TL, Zhou H, Hazuda DJ, Espeseth AS, König R, Bandyopadhyay S, Ideker T, Goff SP, Krogan NJ, Frankel AD, et al. Host cell factors in HIV replication: meta-analysis of genome-wide studies. Plos Pathogens. 5: e1000437. PMID 19478882 DOI: 10.1371/Journal.Ppat.1000437 |
0.537 |
|
| 2008 |
Wilmes GM, Bergkessel M, Bandyopadhyay S, Shales M, Braberg H, Cagney G, Collins SR, Whitworth GB, Kress TL, Weissman JS, Ideker T, Guthrie C, Krogan NJ. A genetic interaction map of RNA-processing factors reveals links between Sem1/Dss1-containing complexes and mRNA export and splicing. Molecular Cell. 32: 735-46. PMID 19061648 DOI: 10.1016/J.Molcel.2008.11.012 |
0.535 |
|
| 2008 |
König R, Zhou Y, Elleder D, Diamond TL, Bonamy GM, Irelan JT, Chiang CY, Tu BP, De Jesus PD, Lilley CE, Seidel S, Opaluch AM, Caldwell JS, Weitzman MD, Kuhen KL, ... Bandyopadhyay S, et al. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell. 135: 49-60. PMID 18854154 DOI: 10.1016/J.Cell.2008.07.032 |
0.541 |
|
| 2008 |
Roguev A, Bandyopadhyay S, Zofall M, Zhang K, Fischer T, Collins SR, Qu H, Shales M, Park HO, Hayles J, Hoe KL, Kim DU, Ideker T, Grewal SI, Weissman JS, et al. Conservation and rewiring of functional modules revealed by an epistasis map in fission yeast. Science (New York, N.Y.). 322: 405-10. PMID 18818364 DOI: 10.1126/Science.1162609 |
0.561 |
|
| 2008 |
Bandyopadhyay S, Kelley R, Krogan NJ, Ideker T. Functional maps of protein complexes from quantitative genetic interaction data. Plos Computational Biology. 4: e1000065. PMID 18421374 DOI: 10.1371/Journal.Pcbi.1000065 |
0.67 |
|
| 2007 |
Beyer A, Bandyopadhyay S, Ideker T. Integrating physical and genetic maps: from genomes to interaction networks. Nature Reviews. Genetics. 8: 699-710. PMID 17703239 DOI: 10.1038/Nrg2144 |
0.634 |
|
| 2006 |
Bandyopadhyay S, Kelley R, Ideker T. Discovering regulated networks during HIV-1 latency and reactivation. Pacific Symposium On Biocomputing. Pacific Symposium On Biocomputing. 354-66. PMID 17094252 |
0.618 |
|
| 2006 |
Bandyopadhyay S, Sharan R, Ideker T. Systematic identification of functional orthologs based on protein network comparison. Genome Research. 16: 428-35. PMID 16510899 DOI: 10.1101/Gr.4526006 |
0.55 |
|
| 2004 |
Bandyopadhyay S, Cookson MR. Evolutionary and functional relationships within the DJ1 superfamily. Bmc Evolutionary Biology. 4: 6. PMID 15070401 DOI: 10.1186/1471-2148-4-6 |
0.341 |
|
| Show low-probability matches. |